Vimarsana
Biggest News Aggregation in the World

Jay Avasarala News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Avasarala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Avasarala Today - Breaking & Trending Today

Study Associates Use of TNF Alpha Inhibitors in Crohn's Disease with Increased Risk of MS - Vimarsana News

Study Associates Use of TNF Alpha Inhibitors in Crohn's Disease with Increased Risk of MS

Dr. Jay Avasarala, professor of neurology and director of UK’s Multiple Sclerosis Clinic, and co-authors, conducted a retrospective study in which they evaluated approximately 96.5 million enrollees in a database. Mark Cornelison l UK Photo LEXINGTON, Ky. (May 11, 2021) — Dr. Jay Avasarala, professor of neurology and director of the University of Kentucky’s Multiple Sclerosis Clinic, and co-authors, conducted a retrospective study in which they evaluated approximately 96.5 million enrollees in a database. More than 200,000 of the enrollees had inflammatory bowel disease (IBD). The res...

Source: uky.edu
UK HealthCare's Multiple Sclerosis Team Earns Certification as Comprehensive Care Center - Vimarsana News

UK HealthCare's Multiple Sclerosis Team Earns Certification as Comprehensive Care Center

of LEXINGTON, Ky. (April 14, 2021) — UK HealthCare’s Multiple Sclerosis (MS) Center, a part of the Kentucky Neuroscience Institute, is celebrating one of its biggest achievements since it was created about three decades ago. The MS Center is now recognized as a Center for Comprehensive Care by the National Multiple Sclerosis Society. To achieve this status a center must address the needs of those living with MS by coordinating multi-disciplinary care, from medical, psycho-social and rehabilitation services, to provide exceptional care. “Being called a Comprehensive MS Care Center impl...

Source: uky.edu
MS Center Director Publishes Editorial on Lack of Minority Representation in Clinical Trials - Vimarsana News

MS Center Director Publishes Editorial on Lack of Minority Representation in Clinical Trials

In an editorial in CNS Spectrums, Dr. Jay Avasarala advocates for increased minority representation in clinical trials for MS drugs. Photo | Mark Mahan LEXINGTON, Ky. (April 2, 2021) — In an editorial recently published in CNS Spectrums, Dr. Jay Avasarala continues to raise a concern he voiced in a previous writing published about two years ago. The question at the center of his editorials – “When will we achieve racial parity?” Avasarala, director of UK HealthCare’s Multiple Sclerosis Center within the Kentucky Neuroscience Institute, says enrollment of people of color in pivotal...

Source: uky.edu